1.
Thyroid cancer
by Cabanillas, Maria E, Dr
The Lancet (British edition), 2016, Vol.388 (10061), p.2783-2795

2.
Vemurafenib in patients with BRAFV600E -positive metastatic or unresectable papillary thyroid cancer refractory to radioactive iodine: a non-randomised, multicentre, open-label, ph...
by Brose, Marcia S, Dr
The lancet oncology, 2016, Vol.17 (9), p.1272-1282
